August 2025 AMR CoP ECHO Session: Antimicrobial Stewardship: Practical Insights for Resource-Limited Settings
22 August 2025 This webinar, titled “Antimicrobial Stewardship: Practical Insights for Resource-Limited Settings,” explores how antimicrobial stewardship (AMS)—when imp
August 2025 AMR CoP ECHO Session: Modelling Societal Burden of AMU/AMR: Introducing Productivity Adjusted Life Years (PALYs)
29 August 2025 This webinar, titled “Modelling Societal Burden of AMU/AMR: Introducing Productivity Adjusted Life Years (PALYs),” expands on the “burden of dise
September 2025 AMR CoP ECHO session: Antimicrobial Resistance Surveillance Landscape Analysis Toolkit
26 September 2025 This session focuses on the AMR Surveillance Landscape Analysis Toolkit—a structured package of tools designed to help countries independently assess and streng
September 2025 LabCoP Extended ECHO Session: From Policy to Practice: The Operational Realities of the South African TB diagnostic multiplatform approach
25th September 2025 TB diagnostic programs have historically relied on a single technology model. However, in high-volume settings, low-complexity molecular platforms alone may not
August 2025 Ext Echo Session: Accelerating TB Diagnostics in Africa – spotlight on near point-of-care diagnostics
28 August 2025 Next generation TB diagnostics that can be placed close to where people with TB seek care, in the community and at primary health care facilities, are on the horizon
August 2025 AMR CoP ECHO session: AMR Surveillance and Data Utilization for Healthcare
15 August 2025 In this session, Dr. Lillian Musila explores how AMR surveillance data can be transformed into actionable insights for clinical care, public health, and policy. She
July 2025 LabCoP Extended ECHO Session: Practical Approaches to tNGS Implementation for Rapid Detection of Drug-Resistant TB: Insights from West Java, Indonesia
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
July 2025 AMR CoP ECHO Session: Success Stories and Challenges in Implementing Infection Prevention and Control (IPC) in Resource-Limited Settings
As we continue to confront the growing threat of antimicrobial resistance, Infection Prevention and Control (IPC) remains one of the most powerful and cost-effective interventions
June 2025 AMR CoP ECHO Session: Simplifying AMR Surveillance by Building Expertise Alongside Automated AMR/C/U Analysis through Africa’s Knowledge
This AMR CoP ECHO session focuses on simplifying AMR surveillance by building expertise alongside automated AMR/C/U analysis through Africa’s Knowledge Hub. This session demonstr
June 2025 LabCoP Extended ECHO Session: Flying blind: the urgent need for rapid detection of bedaquiline-resistant TB
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a